. Author manuscript; available in PMC: 2009 Aug 10.

Published in final edited form as: Am J Epidemiol. 2007 Mar 10;165(9):1076–1087. doi: 10.1093/aje/kwk115

Table 6.

Midlife values (adjusted to age 50) of selected disease risk factors in eligible, invited and the first 2300 AGES-Reykjavik Study participants: Women

WOMEN	Eligible from Reykjavik Study cohort members N=6,749		Invited for AGES-Reykjavik N=1,933		Non-responders to AGES-Reykjavik N=609		AGES-Reykjavik enrollees N=1,324
Selected Risk Factors	Mean	95% CI	Mean	95% CI	Mean	95% CI	Mean	95% CI

TC (mmo1/L)	6.32	6.28,6.35	6.28	6.23,6.33	6.36	6.25,6.46	6.26	6.20,6.32
TG (mmo1/L)	0.91	0.90,0.93	0.88 ^*	0.87,0.90	0.89	0.86,0.93	0.88	0.86,0.90
Fasting Glucose (mmol/L)	4.29	4.27,4.31	4.25 ^*	4.23,4.28	4.29	4.22,4.36	4.23 ^‡	4.21,4.27
SBP (mmHg)	128.1	127.6,128.7	128.5	127.6,129.4	133.1	131.2,135.0	126.7 ^§	125.7,127.8
BMI (kg/m²)	24.9	24.8,25.0	24.7 ^†	24.5,24.8	24.7	24.3,25.1	24.6	24.4,24.9
Smokers (%)	36.3	35.0,37.7	32.3 ^*	30.1,34.5	36.3	32.1, 40.8	30.8 ^‡	28.4,33.5

Abbreviations: CI=Confidence Interval, TC=Total Cholesterol, TG=Triglycerides, SBP=Systolic Blood Pressure, BMI=Body Mass Index

p<0.01 between midlife data of eligible Reykjavik Study cohort members and those invited

^†

p<0.05 between midlife data of eligible Reykjavik Study cohort members and those invited

^‡

p<0.05 between midlife data of non-responders and AGES-Reykjavik Study enrollees

^§

p<0.0001 between midlife data of non-responders and AGES-Reykjavik Study enrollees